🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

‘Remarkable’ tolerability observed with asciminib in a heavily pretreated real-world #CML-CP population Read more: sohoinsider.com/leukemia/chron…

Armored #CAR-T option shows promise in previously CAR-treated #lymphoma sohoinsider.com/lymphoma/hucar…

Stay updated on the latest in hematologic oncology with SOHO Insider, the official publication of the Society of Hematologic Oncology! Subscribe now for exclusive interviews, news updates, and more at sohoinsider.com🩸📰 #HemOnc #bloodcancer

FDA panel votes 8-1 glofitamab trial does not apply to US patients Winship Cancer Institute of Emory University Ajay Nooka, MD, MPH sohoinsider.com/news/fda-odac-…

Congrats to #SOHO Israel for a successful event over the weekend. sohoinsider.com/news/soho-isra…

Congratulations to Dr. Charles Mullighan for being elected as a Fellow of the Royal Society of London. He will be 1 of the #SOHO2025 plenary speakers. Register today: sohoinsider.com/news/keynote-s…

ICYMI: FDA panel votes 6-2 in favor of daratumumab for high-risk smoldering multiple myeloma sohoinsider.com/news/fda-panel…

Jerry Radich of Fred Hutch Cancer Center says "It’s time we use the laws of Darwin against cancer. Maybe it’s time to learn lessons from the land" in this editorial that draws parallels between blood cancer treatment and agricultural pest control. sohoinsider.com/news/making-re…

Less than a week before #ASCO25, subscribe at sohoinsider.com for all the latest meeting news online, in-print, & via podcast.

Taurine, an ingredient in popular energy drinks linked to leukemia growth nature sohoinsider.com/leukemia/ingre…

Early palliative care integration does not reduce #MM patients’ healthcare utilization #ASCO25 sohoinsider.com/meetings-confe…

NCCN recommends pemivibart for #BCL patients at risk of severe COVID-19 Invivyd #COVID sohoinsider.com/news/nccn-reco…

Phase 3 MIDAS trial assesses #MRD-driven approach to consolidation, maintenance therapy in #myeloma #ASCO25 sohoinsider.com/meetings-confe…

New podcast episode with Drs. Andrew Kuykendall MD & Gabriela Hobbs on all-things MPN plus #ASCO25 news Moffitt Cancer Center sohoinsider.com/soho-insider-p…

Sintilimab plus ifosfamide, carboplatin, and etoposide regimen significantly improves complete remission in classical Hodgkin #lymphoma #ASC025 Innovent Solutions sohoinsider.com/meetings-confe…

One more day until early-bird registration rates come & go for #SOHO2025. Register today: sohoonline.org/SOHO2025/SOHO2…

Isatuximab with KRd boosts sustained MRD negativity in myeloma sohoinsider.com/meetings-confe…

New immunotherapy approach may treat aggressive AML, MDS sohoinsider.com/leukemia/tcr-i…

We are preparing for #EHA25! Come say hi at the SOHO booth (M17, right by the Exhibitor Service Center)! We’ve got updates to share and copies of SOHO Insider, our official publication. (And nope, we’re not publishing with BCT anymore.)

Dr. Nieto discusses phase I results of AFM13 in #lymphoma in this video interview sohoinsider.com/news/afm13-lym…